These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 23868003)
1. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. Wheelwright S; Darlington AS; Fitzsimmons D; Fayers P; Arraras JI; Bonnetain F; Brain E; Bredart A; Chie WC; Giesinger J; Hammerlid E; O'Connor SJ; Oerlemans S; Pallis A; Reed M; Singhal N; Vassiliou V; Young T; Johnson C Br J Cancer; 2013 Aug; 109(4):852-8. PubMed ID: 23868003 [TBL] [Abstract][Full Text] [Related]
2. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer. Goo AJ; Shin DW; Yang HK; Park JH; Kim SY; Shin JY; Kim YA; Kim C; Hong NS; Min YJ; Park K J Geriatr Oncol; 2017 Jul; 8(4):271-276. PubMed ID: 28377101 [TBL] [Abstract][Full Text] [Related]
3. Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study. Ditzel HM; Giger AW; Lund CM; Ditzel HJ; Möller S; Pfeiffer P; Ryg J; Ewertz M; Jørgensen TL Lancet Healthy Longev; 2024 Sep; 5(9):100612. PubMed ID: 39217995 [TBL] [Abstract][Full Text] [Related]
4. Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14). Wrazen W; Golec EB; Tomaszewska IM; Walocha E; Dudkiewicz Z; Tomaszewski KA Folia Med Cracov; 2014; 54(2):35-45. PubMed ID: 25648308 [TBL] [Abstract][Full Text] [Related]
5. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20). Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV; Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189 [TBL] [Abstract][Full Text] [Related]
6. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15. Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G; Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993 [TBL] [Abstract][Full Text] [Related]
7. The EORTC QLQ-ELD14 questionnaire for elderly cancer patients. Validation study for elderly Spanish breast cancer patients. Arraras JI; Asin G; Illarramendi JJ; Manterola A; Salgado E; Dominguez MA Rev Esp Geriatr Gerontol; 2019; 54(6):321-328. PubMed ID: 31266659 [TBL] [Abstract][Full Text] [Related]
8. Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer. Kinoshita Y; Izukura R; Kishimoto J; Kanaoka M; Fujita H; Ando K; Nagai S; Akiyoshi S; Tagawa T; Kubo M; Inokuchi J; Ohuchida K; Oki E; Tanaka K; Eto M; Yoshizumi T; Nakamura M; Chishaki A J Cancer Res Clin Oncol; 2023 Jul; 149(8):4899-4914. PubMed ID: 36307557 [TBL] [Abstract][Full Text] [Related]
9. Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module. Kaufmann A; Schmidt H; Ostheimer C; Ullrich J; Landenberger M; Vordermark D Support Care Cancer; 2015 Jul; 23(7):1883-92. PubMed ID: 25475738 [TBL] [Abstract][Full Text] [Related]
10. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26. Arraras JI; Giesinger J; Shamieh O; Bahar I; Koller M; Bredart A; Costantini A; Greimel E; Sztankay M; Wintner LM; de Sousa MC; Ishiki H; Kontogianni M; Wolan M; Kikawa Y; Lanceley A; Gioulbasanis I; Harle A; Zarandona U; Kulis D; Kuljanic K; Health Qual Life Outcomes; 2024 Oct; 22(1):87. PubMed ID: 39385305 [TBL] [Abstract][Full Text] [Related]
11. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB; Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466 [TBL] [Abstract][Full Text] [Related]
12. International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27. Oerlemans S; Efficace F; Shamieh O; Cardoso Borges F; de Jong C; Dong D; Lehmann J; Malak S; Petranovic D; Scholz CW; Caocci G; Molica S; Griskevicius L; Nagele E; Bredart A; Carvalho E; Xochelli A; Agelink van Rentergem J; Alrjoob W; Mueller A; Freitas AC; Cocks K; Creutzberg C; Kyriakou C; van de Poll-Franse L Blood Adv; 2023 Nov; 7(22):7045-7055. PubMed ID: 37738090 [TBL] [Abstract][Full Text] [Related]
13. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26. Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B; BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889 [TBL] [Abstract][Full Text] [Related]
14. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction. Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT; Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657 [TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of the EORTC QLQ-C30 in Uganda. Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718 [TBL] [Abstract][Full Text] [Related]
16. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire. Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M; Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066 [TBL] [Abstract][Full Text] [Related]
17. International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia. Oerlemans S; Efficace F; Kieffer JM; Kyriakou C; Xochelli A; Levedahl K; Petranovic D; Borges FC; Bredart A; Shamieh O; Gziskevicius L; Lehmann J; Scholz CW; Caocci G; Molica S; Stamatopoulos K; Panteliadou AK; Papaioannou M; Alrjoob W; Baliakas P; Rosenquist R; Malak S; Miranda A; Cocks K; van de Poll-Franse L; Br J Haematol; 2022 May; 197(4):431-441. PubMed ID: 35255152 [TBL] [Abstract][Full Text] [Related]
18. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China. Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985 [TBL] [Abstract][Full Text] [Related]
19. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version. Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial. Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]